Spaulding Clinical Research LLC of West Bend announced today it has formed a strategic partnership with Exton, Pa.-based Frontage Laboratories Inc., a global full-service Clinical Research Organization with facilities in the United States and China.
As part of the relationship, Spaulding Clinical will perform all intense electrocardiographic studies in its facility and provide ECG Core Lab services on behalf of Frontage. In return, Frontage will provide bioanalytical method development and sample processing, formulation development and clinical trial product supplies for Spaulding Clinical, as well as serve as one of the clinical sites for Spaulding Clinical clients in China.
"Throughout the due diligence process, we were thoroughly impressed with the innovative, quality-focused clinical conduct we witnessed at Spaulding," said Song Li, PhD, chief executive officer and chairman of Frontage Laboratories. "The collaboration with Spaulding Clinical will enable Frontage to better service our current and potential clients in a more comprehensive approach, especially in the areas of cardiac safety, thorough QT, and ECG Core Lab."
Randy Spaulding, CEO and founder of Spaulding Clinical, said, "This collaboration represents another step forward in meeting our strategic objectives of providing the highest quality global clinical development facilities to our clients interested in accelerating drug development. Together, Frontage and Spaulding Clinical will deliver the first US-based fully-automated Clinical Pharmacology unit in China."
Spaulding Clinical Research forms strategic partnership
advertisement





This image can now be accessed by javascript as document.MyImage. Of course add in the width, height, alt, and border properties as desired too.
The next part is to create a link around that image. This will allow javascript to affect the image properties.
